1. Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria. (29th November 2020) Authors: Rendl, G.; Sipos, B.; Becherer, A.; Sorko, S.; Trummer, C.; Raderer, M.; Hitzl, W.; Ardelt, M.; Gallowitsch, H. J.; Pirich, C. Other Names: Borretta Giorgio Academic Editor. Journal: International journal of endocrinology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗